1/223
Looks like no tags are added yet.
β-Lactam antibiotics: classes and shared MOA
Penicillins, cephalosporins, monobactams, carbapenems (all contain a β-lactam ring) • BACTERICIDAL • Structural analogues of D-ala-D-ala: bind and inactivate PBPs • Block transpeptidation (peptidoglycan cross-linking) • Autolysins released, then cell lysis
PBPs (penicillin-binding proteins)
Enzymes on the inner bacterial cell membrane • Assemble and reshape the cell wall during growth and division • Target of every β-lactam
Main resistance mechanism to penicillins
Bacteria make β-lactamase, which cleaves the β-lactam ring • Fixes: β-lactamase-resistant penicillins (nafcillin, oxacillin) or add an inhibitor (clavulanic acid)
Penicillins: advantages
Bactericidal against sensitive strains • Relatively nontoxic, excellent tissue penetration • Efficacious and inexpensive • Semisynthetic versions have a broader spectrum
Penicillins: disadvantages
Acid lability (some agents) • Short duration of action • Limited against gram-negatives (mainly gram-positive) • Drug hypersensitivity • Resistance when bacteria produce β-lactamase
Penicillin side effects
Diarrhea, nausea • Anemia • Renal toxicity • Hypersensitivity (the big one)
Penicillin clinical uses
Ear, nose, throat infections • Respiratory and urinary tract infections • Prostate infections • Certain sexually transmitted diseases
Natural penicillins
Penicillin G and Penicillin V • Pen V: ORAL, more stable in gastric acid • [+] Pen G is acid-labile, so it is given parenterally
Anti-staphylococcal penicillins (β-lactamase resistant)
Nafcillin, Oxacillin* • Effective against staph that produce β-lactamase • Semisynthetic; bind PBPs and stop cell wall formation
Amoxicillin
Semisynthetic penicillin, broader spectrum; oral (acid-stable) • Binds PBPs, stops cell wall formation • ⚠ Your notes file it under 'β-lactamase-R'. Amoxicillin is actually β-lactamase SENSITIVE, which is why it is paired with clavulanic acid (Augmentin). Check against your slides.
Augmentin
= Clavulanic acid + Amoxicillin • Clavulanic acid inhibits β-lactamases, protecting the β-lactam and enhancing its effectiveness
Cephalosporins: overview
Broad spectrum; structurally and functionally like penicillin • Use if allergic to penicillin (cross-reactivity possible) • Per notes: not affected by β-lactamase because of a large R group • Cons: allergies, thrombophlebitis, renal damage
Cefoxitin
Expanded spectrum of activity • Better anaerobic coverage
Ceftriaxone
Extended spectrum of activity • Used for meningitis and gonorrhea
Carbapenems: Imipenem / cilastatin
Bind PBPs, halting cell wall synthesis • β-lactamases are not effective against them • Cilastatin inhibits dehydropeptidase (renal), preventing degradation of imipenem
Cilastatin: role
Inhibits dehydropeptidase • Prevents breakdown of imipenem, so imipenem lasts longer
Monobactam: Aztreonam
Binds PBPs, halting cell wall synthesis • Gram-negative rods only • Use when allergic to penicillin
Daptomycin
Acts on the cell envelope by causing rapid depolarization • Good against MRSA and vancomycin-resistant organisms
Vancomycin: MOA
Inhibits cell wall synthesis in gram-positive bacteria by targeting D-ala-D-ala • Inhibits transglycosylase and prevents cleavage of the peptidoglycan precursor
Vancomycin: uses
MRSA sepsis • Endocarditis • Staph/strep infection in penicillin allergy • Severe C. diff (oral)
Vancomycin: administration
NOT absorbed orally, so given IV • (oral route only for C. diff, which lives in the gut)
Vancomycin resistance
D-ala-D-ala is changed to D-ala-D-lac, especially in enterococci (VRE; also VRSA) • Treated with a unique 3-pronged approach per notes
Red-neck (red-man) syndrome
Vancomycin • Histamine release causing flushing • Infusion-rate related
Penicillin-allergic patient: alternatives (cell wall)
Cephalosporins (with caution) • Aztreonam (gram-negative rods) • Vancomycin (staph-strep infections)
Ribosomal target cheat sheet
30S: tetracyclines (block tRNA at A site), aminoglycosides (misread mRNA) • 50S: macrolides (block translocation), clindamycin (block translocation), linezolid (blocks initiation complex), chloramphenicol (blocks peptidyl transferase)
Tetracyclines: MOA
Bind the 30S ribosomal subunit • Block binding of tRNA to the A site • Broad spectrum and BACTERIOSTATIC
Tetracyclines: side effects
Teeth discoloration • Renal and hepatic injury • GI upset • Photosensitive rash • Superinfections (e.g. candida vaginitis) • Antagonizes penicillin efficacy
Tetracyclines: who should not get them
Children under 8 years old (teeth discoloration)
Tetracyclines: absorption pearl
Neutralized by chelation with Ca (milk) and other divalent cations
Tetracyclines: uses and resistance
Lyme disease (bull's-eye rash) • Resistance: efflux pump moves drug out, or the ribosome is altered
Doxycycline
Zoonotic disease • Chlamydia, urethritis, PID • Bronchitis, community-acquired pneumonia
Aminoglycosides: MOA
Bind the 30S ribosomal subunit • Interfere with protein synthesis and cause MISREADING of mRNA • BACTERICIDAL
Aminoglycosides: side effects
Deafness and vestibular dysfunction (8th nerve) • Renal damage • Nausea, allergy • Neuromuscular paralysis (inhibit ACh release)
What blocks aminoglycoside entry into bacteria?
Anaerobiasis (anaerobic conditions) • Divalent cations • Hyperosmolarity
Aminoglycosides: dosing concept
Concentration-dependent killing: the higher the concentration, the faster the kill
Aminoglycoside members + mnemonic
Amikacin, Gentamicin, Neomycin*, Streptomycin • Mnemonic: 'Amis Neo gentleman gave her strep'
Streptomycin
First-line for TB (part of RIPES) • Kills gram-negatives; static after hours
Macrolides (-thromycin): MOA
Bind the 50S subunit • Inhibit translocation (A to P site), blocking peptide chain elongation • Bind 23S rRNA of the 50S subunit • Bacteriostatic, broad range
Macrolides: side effects
Hepatic injury, anemia, allergies • GI intolerance • May increase sudden death (prolonged QT, arrhythmias)
Why do macrolides cause GI intolerance?
They are motilin receptor AGONISTS, directly stimulating gut motility
Azithromycin
Wider spectrum than erythromycin • t1/2 about 55-76 hr • Does NOT inhibit CYP450 (fewer drug interactions) • Bind 23S rRNA of 50S, inhibits elongation; static but broad • Uses per notes: chlamydia, Lyme disease
Erythromycin
Inhibits CYP3A4, so it raises serum levels of other drugs • Binds 23S rRNA of 50S; static but broad range • Stimulates gut motility, causing GI intolerance
Clarithromycin
Binds 50S, inhibits CYP3A4 • QT prolongation • Bacteriostatic • Used for H. pylori
Clindamycin (lincosamide)
Binds 50S, blocks translocation, inhibits bacterial protein synthesis
Linezolid (oxazolidinone)
Binds 50S, prevents formation of the initiation complex • Gram-positive incl. MRSA and vancomycin-resistant enterococcus • Cons: thrombocytopenia, anemia, neutropenia, optic neuropathy, peripheral neuropathy, serotonin syndrome
Chloramphenicol
Binds 50S, inhibits peptidyl transferase (peptide bond formation) • Aplastic anemia • Gray baby syndrome
Quinolones: MOA
Inhibit the bacterial DNA gyrase complex, disrupting DNA processes • BACTERICIDAL • Less selective because they hit nucleic acid synthesis
Quinolones: toxicity
GI issues, headache, lightheadedness • Tendonitis • Potential aortic aneurysm
Ciprofloxacin*
Fluoroquinolone; treats ANTHRAX • Increases MMP (breaks down collagen), linked to aortic aneurysm
Levofloxacin*
Fluoroquinolone • Inhibits DNA gyrase + topoisomerase IV
Sulfasalazine
Inhibitor of folate synthesis; decreases folate •
Used in ulcerative colitis and rheumatoid arthritis
anti-inflammatory
Trimethoprim
Inhibitor of folate REDUCTION: blocks DHFR • Less tetrahydrofolate, so less DNA synthesis • Similar effect to methotrexate (MTX)
antibiotic for UTIs, bladder infection, traveler’s diarrhea
Co-trimoxazole
= Trimethoprim + sulfamethoxazole* • Combination folate pathway blockade • [+] Sulfonamide blocks folate synthesis; trimethoprim blocks DHFR (sequential block)
for Pneumocystis pneumonia for ppl w/ HIV
Antifungal targets (big picture)
Fungal cell membrane (ergosterol) or cell wall (β-1,3-glucan) •
Membrane: amphotericin B, nystatin (bind ergosterol); azoles; terbinafine (block ergosterol synthesis) •
Wall: caspofungin •
Nucleic acid: flucytosine
Amphotericin B: MOA and spectrum
Alters membrane permeability by binding ergosterol • Broad coverage; reserved for serious systemic infections (e.g. cryptococcal meningitis) • Not for dermatophytic infections
Amphotericin B: toxicity
Renal tubular damage • Hypokalemia • Chills and fever • Liposomal prep = safer delivery but more expensive
Caspofungin
Inhibits synthesis of β(1,3)-D-glucan (needed for fungal cell wall) • Active against Aspergillus and Candida • (notes say 'bacteriocidal'; it is fungicidal vs Candida)
Flucytosine: MOA
Prodrug related to 5-fluorouracil • Fungal cytosine deaminase converts it to 5-FU, then 5-FdUMP • Selective because fungi, not humans, do the conversion
Flucytosine: PK and uses
Renal elimination, crosses the BBB • Limited to cryptococcus, chromoblastomycosis, some candida • Co-administered with Amphotericin B for cryptococcal meningitis and systemic candida
Azoles (imidazoles and triazoles): MOA
Block demethylation of lanosterol to ergosterol by inhibiting CYP450 (14α-demethylase) • Result: no ergosterol, so a defective fungal membrane • ⚠ Notes say 'cell wall'; it is the membrane (ergosterol)
Fluconazole (most widely used)
Crosses the BBB • Better oral absorption; not dependent on gastric acid • Does not affect human sterol metabolism • Some drug interactions via microsomal P450 inhibition • PO, IV • NOT effective against Aspergillus
Fluconazole + Amphotericin B
Used together for cryptococcal meningitis
Fluconazole vs ketoconazole
Fluconazole: crosses BBB, better oral absorption, no effect on human sterol metabolism, not gastric-acid dependent • Ketoconazole: acidic pH needed, no BBB crossing, interferes with human sterols
Itraconazole*
PO, IV • Histoplasma, Blastomyces, Sporothrix • Active against Aspergillus
Ketoconazole*: spectrum and uses
Broad coverage but NOT active against Aspergillus • Acidic pH needed; does not cross BBB • Oral, gastro-esophageal candidiasis, histoplasmosis, blastomycosis • PO, topical
Ketoconazole: toxicity
Interferes with human sterol metabolism: gynecomastia; blocks gonadal and adrenal androgen synthesis; may block cortisol secretion • Hepatotoxicity • Disulfiram-like reaction (per notes)
Ketoconazole: drug interactions
Inhibits microsomal CYP450: raises cyclosporin and warfarin levels • Rifampin lowers keto levels and keto impairs rifampin absorption • Avoid antacids (need acid)
Posaconazole
PO • Active on Aspergillus • Active versus Mucormycosis (sinuses, brain, lungs)
Voriconazole
PO, IV • Drug of CHOICE for Aspergillus
Clotrimazole
Topical • Dermatophyte infections
Griseofulvin
Dermatophytes (ringworm) • Binds fungal microtubules, disrupting mitosis • Deposits in keratin • Causes photosensitivity
Nystatin
Binds ergosterol, altering membrane permeability • Treats MUCOSAL candidal infections • Side effect: mild GI disturbances
Terbinafine
Squalene epoxidase inhibitor: blocks ergosterol synthesis • Toxic squalene builds up, membrane permeability rises • Dermatophyte onychomycosis (nail fungus), tinea • Metabolized by CYP450; hepatic toxicity; half-life 200-400 hr • Cons: GI issues, headache, rash, liver toxicity
Subcutaneous vs cutaneous mycoses: drug grouping
Systemic/deep: amphotericin B, caspofungin, flucytosine, azoles (flu-, itra-, keto-, posa-, vori-conazole) • Cutaneous: clotrimazole, griseofulvin, nystatin, terbinafine
Aspergillus: which drugs?
Choice: voriconazole • Also active: itraconazole, posaconazole, caspofungin • NOT fluconazole or ketoconazole
Cryptococcal meningitis regimen
Amphotericin B + flucytosine (both cross CNS) • Fluconazole also used with Amp B
PRACTICE: Treatment of dermatophyte infections includes all EXCEPT: A. Terbinafine B. Clotrimazole C. Nystatin D. Fluconazole
Answer: C. Nystatin • Nystatin is for mucosal candidiasis, not dermatophytes • Dermatophyte drugs: terbinafine, clotrimazole, griseofulvin • (fluconazole has some activity but is not a nystatin-type 'mucosal only' agent; C is the intended answer)
Antiviral therapy: general points
Con: bone marrow suppression (granulocytopenia) • Antiretroviral: relapse if stopped • CD4 count is the main predictor • CCR5-tropic HIV-1 = sexual acquisition
HIV treatment (HAART)
Combination of three drugs: reverse transcriptase inhibitors, protease inhibitors, and others • Newly diagnosed: single pill Atripla = efavirenz + emtricitabine + tenofovir (3 antiretrovirals daily)
HIV life cycle (6 steps)
1 Attach: HIV binds CD4 • 2 Enter: virus enters cell • 3 Reverse transcribe: RNA to DNA • 4 Integrate: viral DNA joins host DNA • 5 Assemble: new immature viruses form • 6 Mature: protease makes virus infectious
HIV drug class by life-cycle step
Entry: enfuvirtide (gp41), maraviroc (CCR5) • Reverse transcription: NRTIs, NNRTIs • Integration: -tegravirs • Maturation: protease inhibitors (-navirs)
NRTIs: MOA, toxicity, spectrum
Nucleoside reverse transcriptase inhibitors compete with natural nucleosides: CHAIN TERMINATION • Toxicity: mitochondrial (lactic acidosis, hepatic steatosis) • HIV-1 and HIV-2
NRTI list + mnemonic
Abacavir, Emtricitabine, Lamivudine, Stavudine, Tenofovir, Zidovudine • Mnemonic from notes: AL-STEM-Z
NNRTIs
Efavirenz, Rilpivirine • HIV-1 ONLY (not HIV-2)
Protease inhibitors (-navir)
Lopinavir: HIV-1 only • Ritonavir: HIV-1 and HIV-2 • Block cleavage of GAG-POL polyprotein (maturation)
Enfuvirtide (fusion inhibitor)
Binds the gp41 subunit of the HIV-1 envelope glycoprotein • Prevents conformational changes needed for viral-cell membrane fusion
Maraviroc (CCR5 antagonist)
Blocks the CCR5 co-receptor, stopping entry of CCR5-tropic HIV-1
Integrase inhibitors (-tegravir)
Dolutegravir, Elvitegravir, Raltegravir • Block the strand transfer step; HIV-1 and HIV-2 • Prevent covalent bonds between viral DNA and host DNA
HIV fixed-dose combinations
Lamivudine + Abacavir • Emtricitabine + Tenofovir = Truvada • Zidovudine + Lamivudine • Efavirenz + Emtricitabine + Tenofovir = Atripla • Rilpivirine + Tenofovir + Emtricitabine • Zidovudine + Lamivudine + Abacavir • Elvitegravir + Cobicistat + Tenofovir + Emtricitabine
Amantadine: MOA and use
Influenza A: targets the M2 protein, blocking uncoating (early stage) • Prophylaxis for influenza A; treat within first 48 hr
Amantadine: toxicity
CNS: confusion, nervousness, insomnia, seizures, coma, trouble concentrating • Anticholinergic: blurred vision, dry mouth, palpitations • Caution in glaucoma and prostatic hypertrophy
Rimantadine
Influenza A, M2 blocker, prevents uncoating • Less CNS toxicity than amantadine
Ribavirin
Interferes with viral RNA replication • Toxicity: RBC breakdown, hemolytic anemia
Neuraminidase inhibitors (-amivir)
Influenza A and B • Decrease release of virus from infected cells, increase viral aggregation, decrease spread
Oseltamivir
About 75% effective as prophylaxis; 80% bioavailable; excreted unchanged in urine • AE: nausea, vomiting, headache
Zanamivir
AE: throat discomfort, bronchospasm
Interferon (glycoproteins)
Induces host cell enzymes that block viral protein production (inhibit translation of viral mRNA) • Uses: Kaposi's sarcoma, hairy cell leukemia, condyloma acuminata, laryngeal papillomatosis, chronic hepatitis B • AE: flu-like symptoms, BM suppression, neurotoxicity, alopecia, increased liver enzymes
Pegylated interferon
Longer-lasting interferon • Boosts antiviral immune response
Lamivudine
NRTI, chain termination • Treats HIV and hepatitis B
Tenofovir
NRTI used in HAART • Damages kidney and bones